# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040180
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:26
Documents
19
Period of Report
2025-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM-DEF 14A | tm252430-2_def14a.htm iXBRL | DEF 14A | 934075
4 | GRAPHIC | bc_capandnetincome-4c.jpg | GRAPHIC | 56147
5 | GRAPHIC | bc_capandtsr-4c.jpg | GRAPHIC | 49777
6 | GRAPHIC | px_25astriaproxy1pg1-bw.jpg | GRAPHIC | 287381
7 | GRAPHIC | px_25astriaproxy1pg2-bw.jpg | GRAPHIC | 363803
8 | GRAPHIC | sg_jillcmilne-bw.jpg | GRAPHIC | 5617
| Complete submission text file | 0001104659-25-040180.txt |  | 3659573

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | atxs-20241231.xsd | EX-101.SCH | 6117
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | atxs-20241231_lab.xml | EX-101.LAB | 20406
21 | EXTRACTED XBRL INSTANCE DOCUMENT | tm252430-2_def14a_htm.xml | XML | 182146

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 25880252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)